News + Filings Holdings
All
13F
13D/G
Other
|
|
INTRACOASTAL CAPITAL, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 2.7% stake in Pulmatrix, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.2% stake in ToughBuilt Industries, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6.2% stake in Performance Shipping Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9.6% stake in TIAN RUIXIANG Holdings Ltd |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.6% stake in Petros Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 8.7% stake in Globus Maritime Limited |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.6% stake in Phio Pharmaceuticals Corp. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.3% stake in Histogen Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9% stake in Kiora Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.2% stake in Hoth Therapeutics, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6.3% stake in Agile Therapeutics, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.1% stake in Helius Medical Technologies, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9.4% stake in Enveric Biosciences, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.1% stake in Baudax Bio, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.5% stake in Guardion Health Sciences, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in PharmaCyte Biotech, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Antelope Enterprise Holdings Limited |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.7% stake in Palisade Bio, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.8% stake in Aditxt, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in TIAN RUIXIANG Holdings Ltd |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.9% stake in SOS Limited |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 3.7% stake in ReWalk Robotics Ltd. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.6% stake in Arcadia Biosciences, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.6% stake in Pulmatrix, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.2% stake in Petros Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.9% stake in Plus Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 3.5% stake in Predictive Oncology Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.6% stake in PharmaCyte Biotech, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.7% stake in PHIO Pharmaceuticals Corp. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.4% stake in Palisade Bio, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.4% stake in enVVeno Medical Corporation |
|
|
|